Faculty Detail   
Name MATTHEW A. KUTNY
  
Campus Address ACC 512 Zip 1711
Phone  (205) 638-9285
E-mail  mkutny@uab.edu
Other websites https://www.uab.edu/medicine/peds/hemonc
    

Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Ped - Hematology/Oncology  Ped - Hematology/Oncology Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Professor
Center  Ctr for Clinical & Translational Sci  Ctr for Clinical & Translational Sci Professor

Biographical Sketch 
EDUCATION:
Brown University: BA with Honors in Biomedical Ethics, Magna Cum Laude
Vanderbilt University Medical School: Doctor of Medicine

POST DOCTORAL TRAINING:
Pediatric Internship and Residency: Vanderbilt University Medical Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt
Pediatric Hematology/Oncology Fellowship: University of Washington, Seattle Children’s Hospital, Fred Hutchinson Cancer Research Center

ACADEMIC APPOINTMENTS:
Assistant Professor: University of Alabama, Department of Pediatrics, Division of Hematology and Oncology

HONORS:
Brown University Barker Family National Scholar
Phi Beta Kappa Honor Society (Rhode Island Alpha Chapter: Brown University)
Microbes and Defense Honor Society, Vanderbilt University Medical School
Outstanding Presentation Award at Seattle Children’s Hospital Fellow's Research Day
Accepted to AACR/ASCO Workshop: Methods in Clinical Cancer Research


PROFESSIONAL SOCIETIES:
American Society of Pediatric Hematology/Oncology
American Society of Clinical Oncology
American Society of Hematology

MEMBERSHIPS:
Children’s Oncology Group

Research/Clinical Interest
Title
Clinical and Translational Research in Pediatric Leukemia
Description
Translational research in pediatric leukemia: Identifying leukemia associated genetic mutations for patient risk stratification and treatment allocation. Development of new targeted treatments for relapsed and de novo leukemia. Chair for national clinical trial for acute promyelocytic leukemia under development within the Children’s Oncology Group.

Selected Publications 
Ostronoff F, Othus M, Ho PA, Kutny MA, Geraghty D, Petersdorf SH, Godwin JE, Willman CL, Radich JP, Appelbaum FR, Stirewalt DL, Meshinchi S. Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report. Leukemia, 2012 Jun 22 (Epub ahead of print)
 		  
Kutny MA, Moser BK, Laumann K, Feusner JH, Gamis A, Gregory J, Larson R, Powell B, Woods W, Meshinchi S. FLT3 mutation status as a predictor of early death in pediatric acute promyelocytic leukemia. Pediatric Blood and Cancer, 2012 Oct;59(4):662-7.
 		  
Ho P, Kutny MA, Alonzo TA, Gerbing RB, Joaquin J, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children’s Oncology Group. Pediatric Blood and Cancer, 2011 Aug;57(2):204-9.
 		  
 

Keywords
Pediatric, Leukemia, AML, APL, ALL